Get started
PROBIOTIX HEALTH LS-,05PROBIOTIX HEALTH LS-,05PROBIOTIX HEALTH LS-,05

PROBIOTIX HEALTH LS-,05

No trades
See on Supercharts
Overview
Financials Discussions Seasonals

X90 chart


Full chart

Key stats


Market capitalization
‪9.41 M‬ EUR
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.0075 EUR
Net income (FY)
‪−1.00 M‬ EUR
Revenue (FY)
‪2.22 M‬ EUR
Shares float
‪27.97 M‬
Beta (1Y)
1.28

About PROBIOTIX HEALTH LS-,05


Sector
Health Technology
Industry
Pharmaceuticals: Other
CEO
Steen Raagaard Andersen
Website
probiotixhealth.com
Headquarters
Wakefield
Founded
2021
ISIN
GB00BLNBFR86
FIGI
BBG019XTSZY4
ProBiotix Health Plc engages in the development of probiotic products for cardiovascular disease and other lifestyle conditions. It operates under the following geographical segments: UK, US, and Rest of World. The company was founded by Stephen Patrick O'Hara in 2018 and is headquartered in Wakefield, the United Kingdom.

Check out other big names from the same industry as X90.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange PROBIOTIX HEALTH LS-,05 stocks are traded under the ticker X90.
X90 reached its all-time high on Oct 5, 2022 with the price of 24.5250 EUR, and its all-time low was 0.0215 EUR and was reached on Aug 2, 2024. View more price dynamics on X90 chart.
See other stocks reaching their highest and lowest prices.
Yes, you can track PROBIOTIX HEALTH LS-,05 financials in yearly and quarterly reports right on TradingView.
X90 net income for the last half-year is ‪−698.76 K‬ EUR, while the previous report showed ‪−305.41 K‬ EUR of net income which accounts for −128.79% change. Track more PROBIOTIX HEALTH LS-,05 financial stats to get the full picture.
No, X90 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. PROBIOTIX HEALTH LS-,05 EBITDA is ‪−929.47 K‬ EUR, and current EBITDA margin is −41.64%. See more stats in PROBIOTIX HEALTH LS-,05 financial statements.
Like other stocks, X90 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade PROBIOTIX HEALTH LS-,05 stock right from TradingView charts — choose your broker and connect to your account.